BioSpace News Archive

Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its fourth quarter and fiscal year-end 2020 financial results on Tuesday, July 21, 2020 after the close of trading.

Updated county-level COVID-19 projections released by PolicyLab at Children’s Hospital of Philadelphia forecast a deteriorating situation in communities across Arizona, Texas, and Florida over the next four weeks even as several other previously identified hotspots—including areas in North Carolina, California and Oregon—are projected to flatten their curve.

Appili Therapeutics Inc. (TSXV: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug development, today reported its financial and operational results for the year ended March 31, 2020.

Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced financial and operating results for the quarter ended March 31, 2020.

BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced results for the three month period ended March 31, 2020. Biorem’s complete 2020 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC) that is not curable by surgery or radiation

Bien-Etre Labs, LLC, a nutraceutical development company designing pre- and probiotic supplements to regulate the human biome, as well as researching novel approaches to healthy ageing and longevity, announces the appointment of Mr. Steve P. Prescott to the position of President of the company.

However, high levels of mask wearing could reduce forecasted deaths by nearly 33,060 Next two weeks will show whether surge in deaths follows increase in cases

Leaders of the American Association of Nurse Anesthetists are encouraged by the Centers for Medicare & Medicaid Services announcement on the creation of the Office of Burden Reduction and Health Informatics in an effort to “cut red tape” for providers.

Global biotherapeutics leader CSL Behring announced today that it has agreed to acquire exclusive global license rights to commercialize an adeno-associated virus (AAV) gene therapy program, AMT-061 (etranacogene dezaparvovec), for the treatment of hemophilia B from uniQure (NASDAQ: QURE), a leading gene therapy company.